The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
Keywords: DIO; diet-induced obese; DPP; dipeptidyl peptidase; FAS; fatty acid synthase; FPG; fasting plasma glucose; GDR; glucose disposal rate; HbA1c; glycated hemoglobin; HGP; hepatic glucose production; HPRT; hypoxanthine phosphoribosyltransferase; OGTT; oral gl